Japan Approves Subcutaneous Pembrolizumab Across All Approved Indications
The Big Questions in Cancer Immunotherapy: Can We Treat Toxicity Without Losing Antitumor Immunity?
10 Must-Read Posts In GU Oncology This Week
Erika Hamilton: 10 New FDA-Approved Therapies for Breast Cancer Patients in 5 Months
Rahul Banerjee: Best Myeloma Study I've Ever Put Patients On
Fabrice Barlesi: A Collective Mobilization to Advance Research Against Childhood Cancer
Michael Fradley: Warsaw to Host the International Cardio-Oncology Society GCOS Meeting in 2028
How Do Our Genes Shape Our Lung Cancer Risk? - The Mark Foundation for Cancer Research
